跳至主要内容
临床试验/NCT01140659
NCT01140659已完成不适用

Objective Evaluation of Patients With Palmar Hyperhidrosis Submitted to Two Levels of Sympathectomy: T3 and T4.

University of Sao Paulo1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2007年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Objective measurement of sweat before and after surgery (video-assisted thoracic sympathectomy) T3 and T4.

研究概览

简要总结

Compare the results obtained with video-assisted sympathectomy performed in two distinct levels ganglionic (third versus fourth thoracic ganglion) for the treatment of palmar hyperhidrosis, through a blind randomized clinical trial using an objective method to measure the sweat before and after the operation.

详细描述

Currently, the treatment of choice for treating palmar hyperhidrosis (PH) is video-assisted thoracic sympathectomy (VATS) . This minimally invasive technique has been well standardized and provides adequate results with low morbidity.

The main side effect of VATS is compensatory hyperhidrosis (CH). This is present in most cases and is considered the greatest cause of dissatisfaction. To reduce the risk of CH, various studies have been conducted to compare different levels of ganglion resection. These studies have been based on subjective quantification of sweating (assessment of sweating reported by patients) and on the application of quality-of-life questionnaires.

Recently, tests for the objective evaluation of sweating have been developed to quantify sweating among patients with various diseases, including PH. So far, there have not been any studies comparing the long-term results of thoracic sympathectomy on the third ganglion (G3) versus the fourth ganglion (G4)with objective evaluation to quantify sweating.

The present study was prospective, randomized and blinded, with the objective of comparing the results from VATS at two different resection levels: G3 versus G4. All the patients were followed over a one-year period, and their palmar sweating was quantified using a portable device (VapoMeter) to measure transepidermal water loss (TEWL). In addition, CH was evaluated by applying a specific quality-of-life questionnaire.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
15 Years 至 45 Years(Child, Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Being determined to accomplish the procedure, because such a statement depends on the level of discomfort suffered by the patient.
  • •Absence of previous thoracic surgery.
  • •Concordance with the completion of informed consent.
  • •Preoperative normal, including chest radiograph, electrocardiogram, blood count, sodium, potassium, urea, creatinine, glucose and thyroid hormones.

排除标准

  • •Patients with BMI>
  • •Pregnancy.
  • •Younger than 15 and more than 45 years.
  • •Heart disease that may contraindicate the procedure (congestive heart failure, coronary insufficiency, cardiac arrhythmias, symptomatic, acute myocardial infarction, etc.).
  • •Acute infections or chronic.
  • •Bleeding disorder.
  • •Neoplasms.
  • •Inflammatory diseases of pulmonary or pleural.

研究组 & 干预措施

Objective measurement of sweat

Other

We selected 40 patients from February 2007 to May 2009. All participants were randomized into two groups of 20 patients (G3 and G4) and underwent the sympathectomy, being followed for 12 months. We used an objective method for measuring sweat, checking the "TEWL (transepidermal water loss) measured by the "VapoMeter", and evaluated the quality of life before and after the operation. Also studied were: incidence and intensity of the compensatory hyperhidrosis.

干预措施: Video-assisted sympathectomy (Procedure)

结局指标

主要结局

Objective measurement of sweat before and after surgery (video-assisted thoracic sympathectomy) T3 and T4.

时间窗: 12 months

We used an objective method for measuring sweat, checking the "TEWL (transepidermal water loss) measured by the"VapoMeter". This is a portable instrument that functions noninvasively. It has a closed measurement chamber that eliminates external interference from air currents and enables precise metering of transepidermal water loss (TEWL). The evaporation rate is calculated from the rise in relative air humidity inside the closed chamber of the device, and this value is quantified in g/m²/h (increase in the water mass per unit time per unit of evaporation area).

次要结局

  • Assessment of quality of life.(12 months)
  • Incidence of the compensatory hyperhidrosis(12 months)
  • Intensity of the compensatory hyperhidrosis(12 months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验